Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.390
-0.080 (-3.24%)
At close: Feb 5, 2026
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.08 billion as of February 5, 2026. Its market cap has decreased by -12.01% in one year.
Market Cap
3.08B
Enterprise Value
3.03B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.39
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.08B, an increase of 3,929.02%. That is a compound annual growth rate of 19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 3.08B | -11.60% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.46B |
| Neuren Pharmaceuticals | 1.85B |
| Clarity Pharmaceuticals | 1.10B |
| PYC Therapeutics | 933.22M |
| Opthea | 738.77M |
| Immutep | 589.49M |
| Clinuvel Pharmaceuticals | 562.75M |
| Racura Oncology | 408.36M |